Adenosine
NDC 68083-156, Adenosine, solution, from Gland Pharma Limited.
- Product NDC
- 68083-156
- Status
- Listed
- Labeler
- Gland Pharma Limited
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206778
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68083-156 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADENOSINE3 mg/mL
Pharmacologic classes
Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68083-156-10 | 68083015610 | 10 VIAL in 1 CARTON (68083-156-10) / 2 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1b701a86-3c4e-4c13-bf9e-aa9e73774c20
Use it
Look up 68083-156 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68083-156 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68083-156. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.